A case of pathophysiologic study in Kimura's disease: Measurement of cytokines and surface analysis of eosinophils

Annals of Allergy, Asthma and Immunology

Volumn 81, Issue 5 I, 1998, Pages 423-427

  Tsukadaira, Akihiro ^a   Kitano, Kiyoshi ^a   Okubo, Yoshio ^a   Horie, Shiro ^a   Ito, Makoto ^a   Momose, Tomoyasu ^a   Takashi, Shuji ^a   Itoh, Susumu ^a   Kiyosawa, Kendo ^a   Sekiguchi, Morie ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; IMMUNOGLOBULIN E; INTERLEUKIN 2 RECEPTOR; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

AGED; ANTIGEN EXPRESSION; ARTICLE; CASE REPORT; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; EOSINOPHILIA; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPEROXIDASE STAINING; IMMUNOPHENOTYPING; INFLAMMATION; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 7844248292     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63139-0     Document Type: Article

References (20)

1. Hansel TT, De Vries IJM, Iff T, et al. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 1991;145:105-110.
2. Isoda M. Eosinophil chemotactic factor in tumour tissue from a patient with Kimura's disease. Br J Dermatol 1988; 118:599-603.
3. Enokihara H, Kajitani H, Nagashima S, et al. Interleukin 5 activity in sera from patients with eosinophilia. Br J Haematol 1990;75:458-462.
4. Hansel TT, Walker C. The migration of eosinophils into the sputum of asthmatics: the role of adhesion molecules. Clin Exp Allergy 1992;22: 345-356.
5. Riedel D, Lindemann A, Brach M, et al. Granulocyte-macrophage colony-stimulating factor and interleukin-3 induce surface expression of interleukin-2 receptor p55-chain and CD4 by human eosinophils. Immunology 1990;70:258-261.
6. Rodgers S, Rees RC, Hancock BW. Changes in the phenotypic characteristics of eosinophils from patients receiving recombinant human interleukin-2 (rhIL-2) therapy. Br J Haematol 1994;86:746-753.
7. Sakamoto S, Oki K, Takahasi H, et al. Comparison of surface antigens on eosinophils from patients with eosinophilia. Int Arch Allergy Immunol 1996;111(Suppl 1):26S-28S.
8. Mawhorter SD, Stephany DA, Ottesen EA, Nutman TB. Identification of surface molecules associated with physiologic activation of eosinophils. Application of whole-blood flow cytometry to eosinophils. J Immunol 1996; 156: 4851-4858.
9. Rutella S, Sica S, Rumi C, et al. Hypereosinophilia during 2-chlorodeoxyadenosine treatment for hairy cell leukaemia. Br J Haematol 1996;92: 426-428.
10. Rand TH, Cruikshank WW, Center DM, Weller PF. CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration. J Exp Med 1991;173: 1521-1528.
11. Hossain M, Okubo Y, Horie S, Sekiguchi M. Analysis of recombinant human tumour necrosis factor-α induced CD4 expression on human eosinophils. Immunology 1996;88:301-307.
12. Weller PF. The immunobiology of eosinophils. N Engl J Med 1991;324: 1110-1118.
13. Lucey DR, Dorsky DI, Nicholson-Weller A, Weller PF. Human eosinophils express CD4 protein and bind human immunodeficiency virus 1 gp120. J Exp Med 1989; 169:327-332.
14. Lim KG, Wan HC, Bozza PT, et al. Human eosinophils elaborate the lymphocyte chemoattractants. J Immunol 1996;156:2566-2570.
15. Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood 1994;83:2759-2779.
16. Rubin LA, Kurmann CC, Fritz ME, et al. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 1985; 135:3172-3177.
17. Nelson DL, Rubin LA, Kurman CC, et al. An analysis of the cellular requirements for the production of soluble interleukin-2 receptors in vitro. J Clin Immunol 1986;6:114-120.
18. Rubin LA, Nelson DL. The soluble interleukin-2 receptor: biology, function, and clinical application. Ann Intern Med 1990;113:619-627.
19. Pui CH, Ip SH, Kung P, et al. High serum interleukin-2 receptor levels are related to advanced disease and a poor outcome in childhood non-Hodgkin's lymphoma. Blood 1987;70:624-628.
20. Kniep EM, Strelow I, Lohmann-Matthes ML. The monocyte interleukin-2 receptor light chain: production of cell-associated and soluble interleukin-2 receptor by monocytes. Immunology 1992;75:299-304.